About: Mark Wainberg     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatFellowsOfTheRoyalSocietyOfCanada, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMark_Wainberg&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Mark Arnold Wainberg, OC OQ FRSC (21 April 1945 – 11 April 2017) was a Canadian HIV/AIDS researcher and HIV/AIDS activist. He was the Director of the McGill University AIDS Centre at the Montreal Jewish General Hospital and Professor of Medicine and of Microbiology at McGill University. His laboratory primarily studies HIV reverse transcriptase, the molecular basis for drug resistance, and gene therapy. He received a B.Sc. from McGill University in 1966, a Ph.D. from Columbia University in 1972, and did his post-doctoral research at Hadassah Medical School of the Hebrew University.

AttributesValues
rdf:type
rdfs:label
  • Mark Wainberg (de)
  • Mark Wainberg (es)
  • Mark Wainberg (fr)
  • Mark Wainberg (en)
  • Mark Wainberg (pt)
rdfs:comment
  • Mark Arnold Wainberg (geboren am 21. April 1945 in Montreal; gestorben am 11. April 2017 in Miami, Florida, Vereinigte Staaten) war ein kanadischer Mediziner, der zu AIDS und HIV forschte und 1989 den Arzneistoff Lamivudin (kurz: 3TC) entwickelte. (de)
  • Mark A. Wainberg (Quebec, Canadá, 21 de abril de 1945-Florida, Estados Unidos, 11 de abril del 2017) ​fue un médico e investigador canadiense especializado en infectología, líder de la lucha contra el VIH en Canadá. Fue presidente de la Sociedad Internacional de SIDA de 1998 al 2000.​ (es)
  • Mark Arnold Wainberg, OC OQ FRSC (21 April 1945 – 11 April 2017) was a Canadian HIV/AIDS researcher and HIV/AIDS activist. He was the Director of the McGill University AIDS Centre at the Montreal Jewish General Hospital and Professor of Medicine and of Microbiology at McGill University. His laboratory primarily studies HIV reverse transcriptase, the molecular basis for drug resistance, and gene therapy. He received a B.Sc. from McGill University in 1966, a Ph.D. from Columbia University in 1972, and did his post-doctoral research at Hadassah Medical School of the Hebrew University. (en)
  • Mark Wainberg (21 avril 1945 à Montréal - 11 avril 2017 à Bal Harbour, Floride, États-Unis) est un biologiste et militant canadien (québécois). Selon Michel Sidibé, directeur exécutif d’ONUSIDA, « Mark Wainberg était un géant de la science du VIH » et « son travail a contribué à sauver des millions de vies. » (fr)
  • Mark A. Wainberg (Quebec, Canadá, 21 de abril de 1945-Flórida, Estados Unidos, 11 de abril de 2017), OC, OQ, RSC, foi um médico e pesquisador canadense especializado em doenças infecciosas, líder da luta contra o HIV no Canadá. Foi presidente da Sociedade Internacional de AIDS de 1998 a 2000. (pt)
foaf:name
  • Mark Wainberg (en)
name
  • Mark Wainberg (en)
birth place
death place
death place
death date
birth place
birth date
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 40 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software